Related Experiment Video
Updated: Jul 6, 2026

12:28
Quantification of Vascular Parameters in Whole Mount Retinas of Mice with Non-Proliferative and Proliferative Retinopathies
Published on: March 12, 2022
Retinal vessel analysis reproducibility in assessing cardiovascular disease
Aljoscha S Neubauer1, Matthias Lüdtke, Christos Haritoglou
1Department of Ophthalmology, Ludwig-Maximilians-Universität, Munich, Germany. aljoscha.neubauer@med.uni-muenchen.de
Summary
Semiautomated retinal vessel analysis accurately measures the arteriovenous ratio (AVR), a reproducible risk factor for systemic hypertension and cerebrovascular disease, using routine retinal photographs.
Area of Science:
- Ophthalmology
- Cardiology
- Medical Imaging
Background:
- Established vascular risk factors are crucial for assessing cerebrovascular disease.
- Retinal vessel analysis offers a potential non-invasive method to supplement these factors.
- The clinical accuracy and reproducibility of semiautomated analysis require validation.
Purpose of the Study:
- To assess the clinical accuracy of static, semiautomated retinal vessel analysis.
- To determine the reproducibility of this method for calculating the arteriovenous ratio (AVR).
- To evaluate AVR as a supplementary vascular risk factor.
Main Methods:
- Retinal photographs were obtained from 102 subjects (hypertensive and non-hypertensive) aged >50 years.
- Semiautomated software calculated the arteriovenous ratio (AVR) from retinal images.
- Reproducibility was assessed for software tracking, grader variability, and inter-visit measurements.
Main Results:
- Semiautomated AVR measurements showed excellent agreement with manual methods.
- Retinal AVR correlated significantly with systemic hypertension and gender, but not age.
- The analysis demonstrated high reproducibility with minimal variability from software tracking and graders, though image focus was critical.
Conclusions:
- Semiautomated analysis of retinal AVR is reproducible on routine retinal photographs.
- Retinal AVR is a valuable, relatively independent risk factor for assessing systemic cerebrovascular disease.

